福岡大学 · 薬学科 · 教授

研究キーワードsusumu kaneshige・hidetoshi kamimura・pneumocystis pneumonia・sulfamethoxazole-trimethoprim to atovaquone due・pneumonia a single-center retrospective・pneumocystis pneumonia a single-center・atovaquone due to intolerance・atsushi togawa koichi matsuo・susumu kaneshige masanobu uchiyama・takafumi nakano keisuke sato

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Comparative effectiveness of two first-line, ICI-based regimens for advanced HCC: a target trial emulation using an electronic medical record network.2026 · Frontiers in oncology, 2026年,
• Comparative effectiveness of two first-line, ICI-based regimens for advanced HCC: a target trial emulation using an electronic medical record network. Chihiro Shiraishi; Miho Shigyou; Ryuichi Inoue; Toru Ogura; Susumu Kaneshige; Toshinobu Hayashi Frontiers in oncology, 2026年, 16:1776032 - 1776032 , 査読有り2026 · 論文
• Clinical outcomes after switching from sulfamethoxazole-trimethoprim to atovaquone due to intolerance in patients with non-HIV Pneumocystis pneumonia: a single-center retrospective study.2026 · Journal of pharmaceutical health care and sciences, 2026年01月13日,
• Clinical outcomes after switching from sulfamethoxazole-trimethoprim to atovaquone due to intolerance in patients with non-HIV Pneumocystis pneumonia: a single-center retrospective study. Yukino Shirakawa; Takafumi Nakano; Keisuke Sato; Yuka Takahashi; Mika Higashi; Yukiomi Eguchi; Takuya Yamashina; Tadahiro Ikeuchi; Susumu Kaneshige; Masanobu Uchiyama; Atsushi Togawa; Koichi Matsuo; Hidetoshi Kamimura Journal of pharmaceutical health care and sciences, 2026年01月13日, 12(1):5 - 5 , 査読有り2026 · 論文

• 公式プロフィール